在阿尔茨海默病中NLRP3炎症酶信号传递
Róisín M McManus1, Eicke Latz2
1German Center for Neurodegenerative Diseases (DZNE), Venusberg Campus 1/99, 53127, Bonn, Germany; Institute of Innate Immunity, University Hospital Bonn, Bonn, Germany.
Neuropharmacology
|April 2, 2024
概括
本综述从神经免疫学角度探讨阿尔茨海默病 (AD) 的进展,重点关注NLRP3炎症体. 研究免疫向疗法为治疗这种常见形式的痴呆症提供了新的希望.
科学领域:
- 神经免疫学 神经免疫学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 痴呆症,包括阿尔茨海默病 (AD),每年影响数百万人,预防措施和治疗有限.
- 神经炎症在AD认知衰退的进展中发挥着关键作用.
- NLRP3炎症酶与痴呆症的发病有关.
研究的目的:
- 提供关于阿尔茨海默病进展的神经免疫学观点.
- 在临床前和临床试验中审查免疫向疗法,特别是那些涉及NLRP3炎症酶的疗法.
- 讨论NLRP3炎症酶抑制剂在治疗痴呆症方面的潜力.
主要方法:
- 文献综述专注于神经免疫学和阿尔茨海默病.
- 分析NLRP3炎症酶激活在痴呆症中的作用.
- 目前对NLRP3炎症酶抑制剂进行的临床前和临床研究的总结.
主要成果:
- NLRP3炎症酶是驱动AD的神经炎症过程的关键调解者.
- 目前正在研究针对NLRP3炎症酶及其下游通路的众多抑制剂.
- 这些向疗法显示出可能影响AD发展的潜力.
结论:
- 准NLRP3炎症酶组代表了阿尔茨海默病的有前途的治疗策略.
- 对神经免疫机制和向治疗的进一步研究对于对抗痴呆症至关重要.
- 免疫向的方法为未来的阿尔茨海默病治疗提供了潜力.
更多相关视频
09:04Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
20.9K
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
7.9K
相关概念视频
01:26Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
01:31Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K